Pricing Log in Create free account

Curanex Pharmaceuticals Inc (CURX) vs Karyopharm Therapeutics Inc. (KPTI)

Curanex Pharmaceuticals Inc and Karyopharm Therapeutics Inc. are both Biotechnology companies. Curanex Pharmaceuticals Inc and Karyopharm Therapeutics Inc. are of similar size ($8.0M and $7.6M). Curanex Pharmaceuticals Inc has the higher net margin (0.00% vs −153.3%) and the lower return on invested capital (−356.7% vs 0.00%). Across the 12 metrics below, Curanex Pharmaceuticals Inc leads on 6 and Karyopharm Therapeutics Inc. on 6.

Valuation

Metric CURX KPTI Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.08 9.71
P/B 1.37 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 1.34 9.21
Earnings yield (168.83%) (3,634.56%) (33.15%)
Free cash flow yield (184.34%) (580.28%) (25.50%)

Profitability

Metric CURX KPTI Biotechnology median
Gross margin — 95.89% 65.16%
Operating margin 0.00% (56.17%) 0.00%
Net margin 0.00% (153.28%) 0.00%
Free cash flow margin 0.00% (44.57%) 0.00%
Return on equity (411.10%) 78.98% (56.36%)
Return on assets (357.22%) (207.90%) (48.04%)
Return on invested capital (356.67%) 0.00% 0.00%

Growth

Metric CURX KPTI Biotechnology median
Revenue growth (TTM) — 6.81% 6.02%
EPS growth (last fiscal year) (466.67%) (98.37%) 30.26%
Revenue growth, 5-year CAGR — 6.21% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CURX KPTI Biotechnology median
Debt to equity 0.00 (0.76) 0.00
Current ratio 45.95 0.79 4.72
Net debt to EBITDA 1.20 (2.03) 0.96

Dividend

Metric CURX KPTI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CURX KPTI Biotechnology median
Market cap 7.58m 7.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack